AbbVie Inc.
ABBV 207.94 (-2.10%) 4.37
Health Care
Biotechnology
Quality Checklist 1/8
Est. EPS Growth > 5%
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $367.80(B)
EV: $408.14(B)
Total Equity: $-3.23(B)
Earnings date: Apr-29-2026
P/E: 87.74
Forward P/E: 14.33
P/FCF: 20.63
P/S: 6.02
P/B: N/A
EPS: $2.4
EPS (fwd): $14.5
FCF/share: $10.1
Revenue/share: $34.6
Book value/share: $-1.9
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Debt/Equity: 48
Current Ratio: 0.70
Gross margin: 71.6%
Operating margin: 24.1%
Net margin: 6.9%
Dividend/share: $6.7
Div. yield: 3.20%
TTM Financials
Income (TTM)
Revenue$61.16(B)
Gross profit$43.80(B)
EBITDA$29.25(B)
Net income$4.23(B)
Gross margin71.6%
Operating margin24.1%
Net margin6.9%
Shares outstanding1.77(B)
Balance sheet
Total assets$133.96(B)
Current assets$29.06(B)
Total liabilities$137.19(B)
Current liabilities$43.29(B)
Cash & Short-term inv.$5.26(B)
Long-term debt$58.92(B)
Total intangibles$88.28(B)
PP&E$6.37(B)
Cash flow (TTM)
FCF$17.82(B)
CapEx$-1.21(B)
Dividends paid$-11.66(B)
Stock issued$172.00(M)
Stock repurchased$-980.00(M)
Stock-based comp.$1.05(B)
Debt issued$9.29(B)
Debt repaid$-9.60(B)